0001554795-21-000377.txt : 20211105 0001554795-21-000377.hdr.sgml : 20211105 20211105111540 ACCESSION NUMBER: 0001554795-21-000377 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211105 DATE AS OF CHANGE: 20211105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SALISBURY BANCORP, INC. CENTRAL INDEX KEY: 0001060219 STANDARD INDUSTRIAL CLASSIFICATION: SAVINGS INSTITUTION, FEDERALLY CHARTERED [6035] IRS NUMBER: 061514263 STATE OF INCORPORATION: CT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14854 FILM NUMBER: 211383128 BUSINESS ADDRESS: STREET 1: 5 BISSELL ST STREET 2: PO BOX 1868 CITY: LAKEVILLE STATE: CT ZIP: 06039-1868 BUSINESS PHONE: 8604359801 MAIL ADDRESS: STREET 1: 5 BISSELL ST STREET 2: PO BOX 1868 CITY: LAKEVILLE STATE: CT ZIP: 06039-1868 FORMER COMPANY: FORMER CONFORMED NAME: Salisbury Bancorp, Inc. DATE OF NAME CHANGE: 20210422 FORMER COMPANY: FORMER CONFORMED NAME: SALISBURY BANCORP INC DATE OF NAME CHANGE: 19980420 10-Q 1 sal1027form10q.htm FORM 10-Q
0001060219 false True Q3 12/31 09/30/2021 Non-accelerated Filer True 1400 7000 45000 P7Y P7Y219D P13Y255DT12H P14Y73D 0001060219 2021-01-01 2021-09-30 0001060219 2021-11-02 0001060219 2021-09-30 0001060219 2020-12-31 0001060219 2021-07-01 2021-09-30 0001060219 2020-07-01 2020-09-30 0001060219 2020-01-01 2020-09-30 0001060219 us-gaap:CommonStockMember 2020-06-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001060219 us-gaap:RetainedEarningsMember 2020-06-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-06-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001060219 2020-06-30 0001060219 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001060219 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-07-01 2020-09-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001060219 us-gaap:CommonStockMember 2020-09-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001060219 us-gaap:RetainedEarningsMember 2020-09-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-09-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001060219 2020-09-30 0001060219 us-gaap:CommonStockMember 2021-06-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001060219 us-gaap:RetainedEarningsMember 2021-06-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2021-06-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001060219 2021-06-30 0001060219 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001060219 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2021-07-01 2021-09-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001060219 us-gaap:CommonStockMember 2021-09-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001060219 us-gaap:RetainedEarningsMember 2021-09-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2021-09-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001060219 us-gaap:CommonStockMember 2019-12-31 0001060219 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001060219 us-gaap:RetainedEarningsMember 2019-12-31 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-12-31 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001060219 2019-12-31 0001060219 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001060219 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-01-01 2020-09-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001060219 us-gaap:CommonStockMember 2020-12-31 0001060219 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001060219 us-gaap:RetainedEarningsMember 2020-12-31 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-12-31 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001060219 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001060219 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001060219 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001060219 us-gaap:DeferredCompensationShareBasedPaymentsMember 2021-01-01 2021-09-30 0001060219 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001060219 us-gaap:DebtSecuritiesAvailableForSaleCostOfSecuritySoldOrTransferredMethodSpecificIdentificationMember 2021-09-30 0001060219 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-09-30 0001060219 SAL:AccumulatedNetUnrealizedInvestmentGainLoss1Member 2021-09-30 0001060219 us-gaap:SecuritiesFinancingTransactionFairValueMember 2021-09-30 0001060219 us-gaap:DebtSecuritiesAvailableForSaleCostOfSecuritySoldOrTransferredMethodSpecificIdentificationMember 2020-12-31 0001060219 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0001060219 SAL:AccumulatedNetUnrealizedInvestmentGainLoss1Member 2020-12-31 0001060219 us-gaap:SecuritiesFinancingTransactionFairValueMember 2020-12-31 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesLessThan12MonthsFairValueMember 2021-09-30 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesLessThan12MonthsUnrealizedLossesMember 2021-09-30 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecurities12MonthsOrLongerFairValueMember 2021-09-30 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecurities12MonthsOrLongerUnrealizedLossesMember 2021-09-30 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesTotalFairValueMember 2021-09-30 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesTotalUnrealizedLossesMember 2021-09-30 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesLessThan12MonthsFairValueMember 2020-12-31 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesLessThan12MonthsUnrealizedLossesMember 2020-12-31 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecurities12MonthsOrLongerFairValueMember 2020-12-31 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecurities12MonthsOrLongerUnrealizedLossesMember 2020-12-31 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesTotalFairValueMember 2020-12-31 0001060219 SAL:AggregateFairValueGrossUnrealizedLossOfSecuritiesTotalUnrealizedLossesMember 2020-12-31 0001060219 SAL:USTreasury1Member 2021-09-30 0001060219 SAL:USTreasury1Member 2021-01-01 2021-09-30 0001060219 SAL:USGovernmentAgencyNotes2Member 2021-09-30 0001060219 SAL:USGovernmentAgencyNotes2Member 2021-01-01 2021-09-30 0001060219 SAL:USGovernmentAgencyNotesTotalMember 2021-09-30 0001060219 SAL:USGovernmentAgencyNotesTotalMember 2021-01-01 2021-09-30 0001060219 SAL:USStatesAndPoliticalSubdivisions2Member 2021-09-30 0001060219 SAL:USStatesAndPoliticalSubdivisions2Member 2021-01-01 2021-09-30 0001060219 SAL:USStatesAndPoliticalSubdivisions3Member 2021-09-30 0001060219 SAL:USStatesAndPoliticalSubdivisions3Member 2021-01-01 2021-09-30 0001060219 SAL:USStatesAndPoliticalSubdivisionsTotalMember 2021-09-30 0001060219 SAL:USStatesAndPoliticalSubdivisionsTotalMember 2021-01-01 2021-09-30 0001060219 us-gaap:CorporateDebtSecuritiesMember 2021-09-30 0001060219 us-gaap:CorporateDebtSecuritiesMember 2021-01-01 2021-09-30 0001060219 us-gaap:AvailableforsaleSecuritiesMember 2021-09-30 0001060219 us-gaap:AvailableforsaleSecuritiesMember 2021-01-01 2021-09-30 0001060219 2020-01-01 2020-12-31 0001060219 us-gaap:PassMember 2021-09-30 0001060219 us-gaap:SpecialMentionMember 2021-09-30 0001060219 us-gaap:SubstandardMember 2021-09-30 0001060219 us-gaap:DoubtfulMember 2021-09-30 0001060219 us-gaap:UnlikelyToBeCollectedFinancingReceivableMember 2021-09-30 0001060219 us-gaap:NonperformingFinancingReceivableMember 2021-09-30 0001060219 us-gaap:PassMember 2020-12-31 0001060219 us-gaap:SpecialMentionMember 2020-12-31 0001060219 us-gaap:SubstandardMember 2020-12-31 0001060219 us-gaap:DoubtfulMember 2020-12-31 0001060219 us-gaap:UnlikelyToBeCollectedFinancingReceivableMember 2020-12-31 0001060219 us-gaap:NonperformingFinancingReceivableMember 2021-12-31 0001060219 SAL:LoansReceivableDelinquencyStatusCurrentMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodTwoMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodThreeMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodFourMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodFiveMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodSixMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyAccrualMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyNonAccrualMember 2021-09-30 0001060219 SAL:LoansReceivableDelinquencyStatusCurrentMember 2020-12-31 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodTwoMember 2020-12-31 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodThreeMember 2020-12-31 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodFourMember 2020-12-31 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodFiveMember 2020-12-31 0001060219 SAL:LoansReceivableDelinquencyStatusPeriodSixMember 2020-12-31 0001060219 SAL:LoansReceivableDelinquencyAccrualMember 2020-12-31 0001060219 SAL:LoansReceivableDelinquencyNonAccrualMember 2020-12-31 0001060219 SAL:ResidentialPortfolioSegment1Member 2021-07-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2021-01-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2020-07-01 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2020-01-01 2020-09-30 0001060219 SAL:CommercialRealEstatePortfolioSegment1Member 2020-01-01 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2021-06-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2020-06-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment2Member 2021-06-30 0001060219 SAL:ResidentialPortfolioSegment2Member 2021-07-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment2Member 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment2Member 2020-06-30 0001060219 SAL:ResidentialPortfolioSegment2Member 2020-07-01 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment2Member 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2021-06-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2021-07-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2020-06-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2020-07-01 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2021-06-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2021-07-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2020-06-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2020-07-01 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2020-09-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2021-07-01 2021-09-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2021-09-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2020-06-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2020-07-01 2020-09-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2020-09-30 0001060219 SAL:CommercialPortfolioSegment1Member 2021-06-30 0001060219 SAL:CommercialPortfolioSegment1Member 2021-07-01 2021-09-30 0001060219 SAL:CommercialPortfolioSegment1Member 2021-09-30 0001060219 SAL:CommercialPortfolioSegment1Member 2020-06-30 0001060219 SAL:CommercialPortfolioSegment1Member 2020-07-01 2020-09-30 0001060219 SAL:CommercialPortfolioSegment1Member 2020-09-30 0001060219 SAL:CommercialPortfolioSegment2Member 2021-06-30 0001060219 SAL:CommercialPortfolioSegment2Member 2021-07-01 2021-09-30 0001060219 SAL:CommercialPortfolioSegment2Member 2021-09-30 0001060219 SAL:CommercialPortfolioSegment2Member 2020-06-30 0001060219 SAL:CommercialPortfolioSegment2Member 2020-07-01 2020-09-30 0001060219 SAL:CommercialPortfolioSegment2Member 2020-09-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2021-07-01 2021-09-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2021-09-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2020-06-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2020-07-01 2020-09-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2020-09-30 0001060219 SAL:LandPortfolioSegmentMember 2021-06-30 0001060219 SAL:LandPortfolioSegmentMember 2021-07-01 2021-09-30 0001060219 SAL:LandPortfolioSegmentMember 2021-09-30 0001060219 SAL:LandPortfolioSegmentMember 2020-06-30 0001060219 SAL:LandPortfolioSegmentMember 2020-07-01 2020-09-30 0001060219 SAL:LandPortfolioSegmentMember 2020-09-30 0001060219 SAL:LandPortfolioSegment1Member 2021-06-30 0001060219 SAL:LandPortfolioSegment1Member 2021-07-01 2021-09-30 0001060219 SAL:LandPortfolioSegment1Member 2021-09-30 0001060219 SAL:LandPortfolioSegment1Member 2020-06-30 0001060219 SAL:LandPortfolioSegment1Member 2020-07-01 2020-09-30 0001060219 SAL:LandPortfolioSegment1Member 2020-09-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2021-06-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2021-07-01 2021-09-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2021-09-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2020-06-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2020-07-01 2020-09-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2020-09-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-06-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-07-01 2021-09-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-09-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-06-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-07-01 2020-09-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-09-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2021-06-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2021-07-01 2021-09-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2021-09-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2020-06-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2020-07-01 2020-09-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2020-09-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2021-07-01 2021-09-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2021-09-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2020-06-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2020-07-01 2020-09-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2020-09-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2021-06-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2021-07-01 2021-09-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2021-09-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2020-06-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2020-07-01 2020-09-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2020-09-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2021-06-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2021-07-01 2021-09-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2021-09-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2020-06-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2020-07-01 2020-09-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment1Member 2020-12-31 0001060219 SAL:ResidentialPortfolioSegment1Member 2019-12-31 0001060219 SAL:ResidentialPortfolioSegment2Member 2020-12-31 0001060219 SAL:ResidentialPortfolioSegment2Member 2021-01-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment2Member 2019-12-31 0001060219 SAL:ResidentialPortfolioSegment2Member 2020-01-01 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2020-12-31 0001060219 SAL:ResidentialPortfolioSegment3Member 2021-01-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment3Member 2019-12-31 0001060219 SAL:ResidentialPortfolioSegment3Member 2020-01-01 2020-09-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2020-12-31 0001060219 SAL:ResidentialPortfolioSegment4Member 2021-01-01 2021-09-30 0001060219 SAL:ResidentialPortfolioSegment4Member 2019-12-31 0001060219 SAL:ResidentialPortfolioSegment4Member 2020-01-01 2020-09-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2020-12-31 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2021-01-01 2021-09-30 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2019-12-31 0001060219 us-gaap:ResidentialPortfolioSegmentMember 2020-01-01 2020-09-30 0001060219 SAL:CommercialPortfolioSegment1Member 2020-12-31 0001060219 SAL:CommercialPortfolioSegment1Member 2021-01-01 2021-09-30 0001060219 SAL:CommercialPortfolioSegment1Member 2019-12-31 0001060219 SAL:CommercialPortfolioSegment1Member 2020-01-01 2020-09-30 0001060219 SAL:CommercialPortfolioSegment2Member 2020-12-31 0001060219 SAL:CommercialPortfolioSegment2Member 2021-01-01 2021-09-30 0001060219 SAL:CommercialPortfolioSegment2Member 2019-12-31 0001060219 SAL:CommercialPortfolioSegment2Member 2020-01-01 2020-09-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2020-12-31 0001060219 us-gaap:CommercialPortfolioSegmentMember 2021-01-01 2021-09-30 0001060219 us-gaap:CommercialPortfolioSegmentMember 2019-12-31 0001060219 us-gaap:CommercialPortfolioSegmentMember 2020-01-01 2020-09-30 0001060219 SAL:LandPortfolioSegmentMember 2020-12-31 0001060219 SAL:LandPortfolioSegmentMember 2021-01-01 2021-09-30 0001060219 SAL:LandPortfolioSegmentMember 2019-12-31 0001060219 SAL:LandPortfolioSegmentMember 2020-01-01 2020-09-30 0001060219 SAL:LandPortfolioSegment1Member 2020-12-31 0001060219 SAL:LandPortfolioSegment1Member 2021-01-01 2021-09-30 0001060219 SAL:LandPortfolioSegment1Member 2019-12-31 0001060219 SAL:LandPortfolioSegment1Member 2020-01-01 2020-09-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2020-12-31 0001060219 SAL:RealEstatePortfolioSegmentMember 2021-01-01 2021-09-30 0001060219 SAL:RealEstatePortfolioSegmentMember 2019-12-31 0001060219 SAL:RealEstatePortfolioSegmentMember 2020-01-01 2020-09-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-12-31 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-01-01 2021-09-30 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2019-12-31 0001060219 us-gaap:CommercialRealEstatePortfolioSegmentMember 2020-01-01 2020-09-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2020-12-31 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2021-01-01 2021-09-30 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2019-12-31 0001060219 SAL:CommercialGovernmentsPortfolioSegmentMember 2020-01-01 2020-09-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2020-12-31 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2021-01-01 2021-09-30 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2019-12-31 0001060219 us-gaap:ConsumerPortfolioSegmentMember 2020-01-01 2020-09-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2020-12-31 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2021-01-01 2021-09-30 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2019-12-31 0001060219 us-gaap:UnallocatedFinancingReceivablesMember 2020-01-01 2020-09-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2020-12-31 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2021-01-01 2021-09-30 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2019-12-31 0001060219 SAL:FinanceLeasesPortfolioTotalSegmentMember 2020-01-01 2020-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesCollectivelyEvaluatedLoansMember 2021-09-30 0001060219 us-gaap:AllowanceForLoanAndLeaseLossesRealEstateMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesIndividuallyEvaluatedLoansMember 2021-09-30 0001060219 us-gaap:AllowanceForLoanAndLeaseLossesMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioLoansMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioAllowanceMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesCollectivelyEvaluatedLoansMember 2020-12-31 0001060219 us-gaap:AllowanceForLoanAndLeaseLossesRealEstateMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesIndividuallyEvaluatedLoansMember 2020-12-31 0001060219 us-gaap:AllowanceForLoanAndLeaseLossesMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioLoansMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioAllowanceMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesCollectivelyEvaluatedLoansCreditQualitySegmentMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesCollectivelyEvaluatedAllowanceCreditQualitySegmentMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesIndividuallyEvaluatedLoansCreditQualitySegmentMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesIndividuallyEvaluatedAllowanceCreditQualitySegmentMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioLoansCreditQualitySegmentMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioAllowanceCreditQualitySegmentMember 2021-09-30 0001060219 SAL:AllowanceForLoanAndLeaseLossesCollectivelyEvaluatedLoansCreditQualitySegmentMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesCollectivelyEvaluatedAllowanceCreditQualitySegmentMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesIndividuallyEvaluatedLoansCreditQualitySegmentMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesIndividuallyEvaluatedAllowanceCreditQualitySegmentMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioLoansCreditQualitySegmentMember 2020-12-31 0001060219 SAL:AllowanceForLoanAndLeaseLossesTotalPortfolioAllowanceCreditQualitySegmentMember 2020-12-31 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceBookMember 2021-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceNoteMember 2021-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceAverageMember 2021-09-30 0001060219 us-gaap:ValuationAllowanceForImpairmentOfRecognizedServicingAssetsMember 2021-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanIncomeRecognizedMember 2021-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceBookMember 2021-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceNoteMember 2021-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceAverageMember 2021-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanIncomeRecognizedMember 2021-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceBookMember 2020-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceNoteMember 2020-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceAverageMember 2020-09-30 0001060219 us-gaap:ValuationAllowanceForImpairmentOfRecognizedServicingAssetsMember 2020-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanIncomeRecognizedMember 2020-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceBookMember 2020-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceNoteMember 2020-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceAverageMember 2020-09-30 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanIncomeRecognizedMember 2020-09-30 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceRecordedInvestmentMember 2020-12-31 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceNoteMember 2020-12-31 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanBalanceAverageMember 2020-12-31 0001060219 us-gaap:ValuationAllowanceForImpairmentOfRecognizedServicingAssetsMember 2020-12-31 0001060219 SAL:ImpairedLoansSpecificAllowanceLoanIncomeRecognizedMember 2020-12-31 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceRecordedInvestmentMember 2020-12-31 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceNoteMember 2020-12-31 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanBalanceAverageMember 2020-12-31 0001060219 SAL:ImpairedLoansNoSpecificAllowanceLoanIncomeRecognizedMember 2020-12-31 0001060219 SAL:AssetsAndLiabilitiesMember 2021-09-30 0001060219 SAL:AssetsAndLiabilitiesMember 2020-12-31 0001060219 SAL:OperatingLeasesMember 2021-09-30 0001060219 SAL:FinanceLeasesMember 2021-09-30 0001060219 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-09-30 0001060219 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2020-12-31 0001060219 us-gaap:GuaranteeTypeOtherMember 2021-09-30 0001060219 us-gaap:GuaranteeTypeOtherMember 2020-12-31 0001060219 SAL:HedgedAssetsLiabilitiesCarryingAmountMember 2021-09-30 0001060219 SAL:HedgedAssetsLiabilitiesCarryingAmountMember 2020-12-31 0001060219 SAL:NotionalAmountMember 2021-09-30 0001060219 SAL:DerivativeInstrumentFairValueMember 2021-09-30 0001060219 SAL:DerivativeInstrumentFairValueMember 2020-12-31 0001060219 SAL:InterestIncomeDerivativeInstrumentMember 2021-07-01 2021-09-30 0001060219 SAL:InterestExpenseDerivativeInstrumentMember 2021-07-01 2021-09-30 0001060219 SAL:InterestIncomeDerivativeInstrumentMember 2021-01-01 2021-09-30 0001060219 SAL:InterestExpenseDerivativeInstrumentMember 2021-01-01 2021-09-30 0001060219 SAL:InterestIncomeDerivativeInstrumentMember 2020-07-01 2020-09-30 0001060219 SAL:InterestExpenseDerivativeInstrumentMember 2020-07-01 2020-09-30 0001060219 SAL:InterestIncomeDerivativeInstrumentMember 2020-01-01 2020-09-30 0001060219 SAL:InterestExpenseDerivativeInstrumentMember 2020-01-01 2020-09-30 0001060219 2021-03-31 0001060219 SAL:TotalCapitalToRiskWeightedAssetsMember 2021-09-30 0001060219 SAL:Tier1CapitalToRiskWeightedAssetsMember 2021-09-30 0001060219 SAL:CommonEquityTier1CapitalToRiskWeightedAssetsMember 2021-09-30 0001060219 SAL:Tier1CapitalToAverageAssetsMember 2021-09-30 0001060219 SAL:TotalCapitalToRiskWeightedAssetsMember 2020-12-31 0001060219 SAL:Tier1CapitalToRiskWeightedAssetsMember 2020-12-31 0001060219 SAL:CommonEquityTier1CapitalToRiskWeightedAssetsMember 2020-12-31 0001060219 SAL:Tier1CapitalToAverageAssetsMember 2020-12-31 0001060219 2021-01-01 2021-12-31 0001060219 2019-01-01 2019-09-30 0001060219 2021-01-01 2021-03-31 0001060219 2020-01-01 2020-03-31 0001060219 SAL:FairValueInputsLevel1SALMember 2021-09-30 0001060219 SAL:FairValueInputsLevel2SALMember 2021-09-30 0001060219 SAL:FairValueInputsLevel3SALMember 2021-09-30 0001060219 SAL:FairValueInputsLevel12And3SALMember 2021-09-30 0001060219 SAL:FairValueInputsLevel1SALMember 2020-12-31 0001060219 SAL:FairValueInputsLevel2SALMember 2020-12-31 0001060219 SAL:FairValueInputsLevel3SALMember 2020-12-31 0001060219 SAL:FairValueInputsLevel12And3SALMember 2020-12-31 0001060219 SAL:CarryingReportedAmountFairValueDisclosureSALMember 2021-09-30 0001060219 SAL:EstimateOfFairValueFairValueDisclosureSALMember 2021-09-30 0001060219 SAL:FairValueInputsLevel1SALMember 2021-09-30 0001060219 SAL:FairValueInputsLevel2SALMember 2021-09-30 0001060219 SAL:FairValueInputsLevel3SALMember 2021-09-30 0001060219 SAL:CarryingReportedAmountFairValueDisclosureSALMember 2020-12-31 0001060219 SAL:EstimateOfFairValueFairValueDisclosureSALMember 2020-12-31 0001060219 SAL:FairValueInputsLevel1SALMember 2020-12-31 0001060219 SAL:FairValueInputsLevel2SALMember 2020-12-31 0001060219 SAL:FairValueInputsLevel3SALMember 2020-12-31 0001060219 2021-11-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SAL:Integer

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2021

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM ________ TO ________

 

Commission file number 0-24751

SALISBURY BANCORP, INC.

(Exact name of registrant as specified in its charter)

Connecticut 06-1514263
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
   
5 Bissell Street, Lakeville, CT 06039
(Address of principal executive offices) (Zip code)

(860) 435-9801

(Registrant's telephone number, including area code) 

Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, Par Value $0.10 per share SAL NASDAQ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act).

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No

The number of shares of Common Stock outstanding as of November 2, 2021 is 2,861,697.

 
 

 

 

TABLE OF CONTENTS

 

PART 1 FINANCIAL INFORMATION Page
Item 1. Financial Statements (unaudited)
CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2021 (unaudited) AND DECEMBER 31, 2020 3
CONSOLIDATED STATEMENTS OF INCOME FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (unaudited) 4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (unaudited) 5
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (unaudited) 5
CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (unaudited) 7
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS 9
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 31
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 47
Item 4. CONTROLS AND PROCEDURES 48
     
PART II. OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS 48
Item 1A. RISK FACTORS 48
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 48
Item 3. DEFAULTS UPON SENIOR SECURITIES 48
Item 4. MINE SAFETY DISCLOSURES 48
Item 5. OTHER INFORMATION 48
Item 6. EXHIBITS 49
SIGNATURES 49

 

 

 2 

 

PART I - FINANCIAL INFORMATION

Salisbury Bancorp, Inc. and Subsidiary

CONSOLIDATED BALANCE SHEETS (unaudited)

(in thousands, except share data)   

September 30, 2021

(unaudited)

     December 31, 2020  
ASSETS          
Cash and due from banks  $7,874   $10,599 
Interest bearing demand deposits with other banks   158,421    82,563 
Total cash and cash equivalents   166,295    93,162 
Interest bearing Time Deposits with Financial Institutions   750    750 
Securities          
Available-for-sale at fair value   175,568    98,411 
CRA mutual fund at fair value   907    917 
Federal Home Loan Bank of Boston stock at cost   1,504    1,713 
Loans held-for-sale   639    2,735 
Loans receivable, net (allowance for loan losses: $13,168 and $13,754)   1,057,451    1,027,738 
Bank premises and equipment, net   20,056    20,355 
Goodwill   13,815    13,815 
Intangible assets (net of accumulated amortization: $5,405 and $5,207)   476    674 
Accrued interest receivable   5,932    6,373 
Cash surrender value of life insurance policies   25,067    21,182 
Deferred taxes   2,776    2,412 
Other assets   5,613    3,423 
Total Assets  $1,476,849   $1,293,660 
LIABILITIES and SHAREHOLDERS' EQUITY          
Deposits          
Demand (non-interest bearing)  $392,322   $310,769 
Demand (interest bearing)   220,533    218,869 
Money market   328,392    278,146 
Savings and other   224,286    189,776 
Certificates of deposit   124,095    131,514 
Total deposits   1,289,628    1,129,074 
Repurchase agreements   10,450    7,116 
Federal Home Loan Bank of Boston advances   8,905    12,639 
Subordinated debt   24,460    9,883 
Note payable   180    208 
Finance lease obligations   1,631    1,673 
Accrued interest and other liabilities   8,062    8,315 
Total Liabilities   1,343,316    1,168,908 
Shareholders' Equity          
Common stock - $0.10 per share par value          
Authorized: 5,000,000;          
Issued: 2,861,697 and 2,843,292          
Outstanding: 2,861,697 and 2,843,292   286    284 
Unearned compensation - restricted stock awards   (1,075)   (774)
Paid-in capital   46,278    45,264 
Retained earnings   86,740    76,974 
Accumulated other comprehensive income, net   1,304    3,004 
Total Shareholders' Equity   133,533    124,752 
Total Liabilities and Shareholders' Equity  $1,476,849   $1,293,660 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 3 

 

Salisbury Bancorp, Inc. and Subsidiary

CONSOLIDATED STATEMENTS OF INCOME (unaudited)

                
     Three months ended      Nine months ended  
Periods ended September 30, (in thousands, except per share amounts) 2021      2020      2021      2020  
Interest and dividend income                    
Interest and fees on loans  $10,264   $10,362   $30,642   $30,662 
Interest on debt securities                    
Taxable   486    396    1,398    1,260 
Tax exempt   172    157    506    513 
Other interest and dividends   79    87    174    229 
Total interest and dividend income   11,001    11,002    32,720    32,664 
Interest expense                    
Deposits   532    764    1,652    3,261 
Repurchase agreements   5    6    13    16 
Finance lease   33    35    102    106 
Note payable   3    3    9    11 
Subordinated debt   233    156    767    468 
Federal Home Loan Bank of Boston advances   30    113    96    472 
Total interest expense   836    1,077    2,639    4,334 
Net interest and dividend income   10,165    9,925    30,081    28,330 
Provision (release) for loan losses   400    686    (517)   4,198 
Net interest and dividend income after provision (release) for loan losses   9,765    9,239    30,598    24,132 
Non-interest income                    
Trust and wealth advisory   1,286    1,068    3,685    3,129 
Service charges and fees   1,211    711    3,536    2,214 
Mortgage banking activities, net   108    736    912    1,182 
(Losses) gains on CRA mutual fund   (4)   -    (18)   22 
Gains (losses) on securities, net   7    34    (2)   216 
Bank-owned life insurance ("BOLI") income   135    719    386    986 
Gain on sale of assets   73    -    73    - 
Other   24    18    81    97 
Total non-interest income   2,840    3,286    8,653    7,846 
Non-interest expense                    
Salaries   3,361    3,114    9,664    8,375 
Employee benefits   1,322    1,061    3,990    3,244 
Premises and equipment   1,060    1,005    3,034    2,897 
Write-down of assets   144    -    144    - 
Data processing   632    569    1,824    1,666 
Professional fees   735    635    2,090    2,020 
Collections, OREO, and loan related   120    108    317    212 
FDIC insurance   146    123    370    331 
Marketing and community support   256    126    552    419 
Amortization of intangibles   61    78    198    247 
Other   447    440    1,448    1,572 
Total non-interest expense   8,284    7,259    23,631    20,983 
Income before income taxes   4,321    5,266    15,620    10,995 
Income tax provision   868    910    3,288    1,858 
Net income  $3,453   $4,356   $12,332   $9,137 
Net income available to common shareholders  $3,400   $4,288   $12,148   $9,006 
                     
Basic earnings per common share  $1.21   $1.53   $4.32   $3.22 
Diluted earnings per common share  $1.20   $1.53   $4.30   $3.21 
Common dividends per share  $0.31   $0.29   $0.90   $0.87 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 4 

 

Salisbury Bancorp, Inc. and Subsidiary

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)

                    
     Three months ended      Nine months ended  
Periods ended September 30, (in thousands)    2021      2020      2021      2020  
Net income  $3,453   $4,356   $12,332   $9,137 
Other comprehensive income                    
Net unrealized (losses) gains on securities available-for-sale   (1,199)   113    (2,153)   1,912 
Reclassification of net realized (gains) losses in net income (1)   (7)   (34)   2    (216)
Unrealized (losses) gains on securities available-for-sale   (1,206)   79    (2,151)   1,696 
Income tax benefit (expense)   254    (17)   451    (357)
Unrealized (losses) gains on securities available-for-sale, net of tax   (952)   62    (1,700)   1,339 
Comprehensive income  $2,501   $4,418   $10,632   $10,477 

 

(1) Reclassification adjustments include realized security gains and losses. The gains and losses have been reclassified out of accumulated other comprehensive income (loss) and have affected certain lines in the consolidated statements of income as follows: The pre-tax amount is reflected as gains (losses) on securities, net, the tax effect is included in the income tax provision and the after tax amount is included in net income. The net tax effect for the three months ending September 30, 2021 and 2020 are $(1) thousand and $(7) thousand, respectively. The net tax effect for the nine months ending September 30, 2021 and 2020 were $1 thousand and ($45) thousand, respectively.

Salisbury Bancorp, Inc. and Subsidiary

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (unaudited)

Three months ended September 30,
(dollars in thousands)

  Common Stock  Paid-in  Retained  Unearned compensation- restricted stock  Accumulated other comprehensive  Total shareholders'
   Shares  Amount  Capital  Earnings  awards  income  equity
Balances at June 30, 2020   2,843,292   $284   $45,096   $71,461   $(1,031)  $2,634   $118,444 
Net income   -    -    -    4,356    -    -    4,356 
Other comprehensive income, net of tax   -    -    -    -    -    62    62 
Common stock dividends declared ($0.29 per share)   -    -    -    (822)   -    -    (822)
Issuance of restricted common stock   500    -    18    -    (18)   -    - 
Forfeiture of stock awards   (500   -    (21   -    21   -    - 
Stock based compensation-restricted stock awards   -    -    78    -    122    -    200 
Balances at September 30, 2020   2,843,292   $284   $45,171   $74,995   $(906)  $2,696   $122,240 
Balances at June 30, 2021   2,861,697   $286   $46,217   $84,174   $(1,224)  $2,256   $131,709 
Net income   -    -    -    3,453    -    -    3,453 
Other comprehensive loss, net of tax   -    -    -    -    -    (952)   (952)
Common stock dividends declared ($0.31 per share)   -    -    -    (887)   -    -    (887)
Stock based compensation-restricted stock awards   -    -    61    -    149    -    210 
Balances at September 30, 2021   2,861,697   $286   $46,278   $86,740   $(1,075)  $1,304   $133,533 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 5 

 

Nine months ended September 30,
(dollars in thousands)

  Common Stock  Paid-in  Retained  Unearned compensation- restricted stock  Accumulated other comprehensive  Total shareholders'
   Shares  Amount  Capital  Earnings  awards  income (loss)  equity
Balances at December 31, 2019   2,825,912   $283   $44,490   $68,320   $(795)  $1,357   $113,655 
Net income for period   -    -    -    9,137    -    -    9,137 
Other comprehensive income, net of tax   -    -    -    -    -    1,339    1,339 
Common stock dividends declared ($0.87 per share)   -    -    -    (2,462)   -    -    (2,462)
Stock options exercised   3,105    -    53    -    -    -    53 
Issuance of restricted common stock   12,275    1    439    -    (440)   -    - 
Forfeiture of stock awards   (1,200)   -    (50)   -    50    -    - 
Issuance of director's restricted stock awards   3,200    -    114    -    (114)   -    - 
Stock based compensation-restricted stock awards   -    -    125    -    393    -    518 
Balances at September 30, 2020   2,843,292   $284   $45,171   $74,995   $(906)  $2,696   $122,240 
Balances at December 31, 2020   2,843,292   $284   $45,264   $76,974   $(774)  $3,004   $124,752 
Net income for period   -    -    -    12,332    -    -    12,332 
Other comprehensive loss, net of tax   -    -    -    -    -    (1,700)   (1,700)
Common stock dividends declared ($0.90 per share)   -    -    -    (2,566)   -    -    (2,566)
Stock options exercised   1,755    1    30    -    -    -    31 
Issuance of restricted common stock   13,850    1    623    -    (624)   -    - 
Issuance of director's restricted stock awards   2,800    -    126    -    (126)   -    - 
Stock based compensation-restricted stock awards   -    -    235    -    449    -    684 
Balances at September 30, 2021   2,861,697   $286   $46,278   $86,740   $(1,075)  $1,304   $133,533 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 6 

 

Salisbury Bancorp, Inc. and Subsidiary

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

Nine months ended September 30, (in thousands)    2021      2020  
Operating Activities          
Net income  $12,332   $9,137 
Adjustments to reconcile net income to net cash provided by operating activities          
(Accretion), amortization and depreciation          
Securities   807    388 
Bank premises and equipment   1,142    1,071 
Core deposit intangible   198    247 
Modification fees on Federal Home Loan Bank of Boston advances   17    64 
Subordinated debt issuance costs   159    18 
Mortgage servicing rights   167    84 
Fair value adjustment on deposits   -    (4)
(Gains) and losses, including write-downs          
Sales and calls of securities available-for-sale, net   2    (216)
CRA Mutual Fund   18    (22)
Sales of loans, excluding capitalized servicing rights   (653)   (843)
Loss on write-down of asset   144    - 
Gain on sale of premises and equipment   (73)   - 
(Release) provision for loan losses   (517)   4,198 
Proceeds from loans sold   30,364    45,246 
Loans originated for sale   (27,615)   (46,832)
(Decrease) increase in deferred loan origination fees and costs, net   (58)   2,321 
Mortgage servicing rights originated   (276)   (413)
Decrease (increase) in interest receivable   441    (2,640)
Decrease (increase) in deferred tax benefit   87    (1,359)
(Increase) decrease in prepaid expenses   (416)   295 
Increase in cash surrender value of life insurance policies   (386)   (986)
Increase in income tax receivable   (429)   - 
(Decrease) increase in income tax payable   (320)   1,412 
(Increase) decrease in other assets   (509)   42 
Decrease in accrued expenses   (290)   (584)
(Decrease) increase in interest payable   (9)   132 
Increase (decrease) in other liabilities   366    (144)
Stock based compensation-restricted stock awards   684    518 
Net cash provided by operating activities   15,378    11,130 
Investing Activities          
Net redemption of Federal Home Loan Bank of Boston stock   209    84 
Purchases of securities available-for-sale   (107,811)   (27,802)
Proceeds from sales of securities available-for-sale   3,311    12,526 
Proceeds from calls of securities available-for-sale   8,500    655 
Proceeds from principal payments and maturities of securities available-for-sale   15,883    12,226 
Reinvestment of CRA Mutual Fund   (8)   (12)
Loan originations and principal collections, net   (29,323)   (110,743)
Recoveries of loans previously charged off   185    44 
Proceeds from sale/ disposal of premises and equipment   248    314 
Capital expenditures   (1,889)   (2,384)
Purchase of life insurance policies   (3,500)   - 
Proceeds from life insurance policy   -    3,994 
Net cash used by investing activities  $(114,195)  $(111,098)

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 7 

 

Salisbury Bancorp, Inc. and Subsidiary

CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

Nine months ended September 30, (in thousands)    2021      2020  
Financing Activities          
Increase in deposit transaction accounts, net  $167,973   $175,508 
(Decrease) increase in time deposits, net   (7,419)   131 
Increase in securities sold under agreements to repurchase, net   3,334    2,355 
Federal Home Loan Bank of Boston long term advances   -    46,001 
Federal Home Loan Bank of Boston long-term maturities/payments   -    (21,000)
Federal Home Loan Bank of Boston short-term advances, net change   -    (30,000)
Principal payments on Amortizing Federal Home Loan Bank of Boston advance   (3,751)   (2,072)
Issuance of Sub Debt, net of issuance costs   24,418    - 
Repayment of Sub Debt   (10,000)   - 
Principal payments on note payable   (28)   (28)
Decrease in finance lease obligation   (42)   (62)
Stock options exercised   31    53 
Common stock dividends paid   (2,566)   (2,462)
Net cash provided by financing activities   171,950    168,424 
Net increase in cash and cash equivalents   73,133    68,456 
Cash and cash equivalents, beginning of period   93,162    26,885 
Cash and cash equivalents, end of period  $166,295   $95,341 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

Salisbury Bancorp, Inc. and Subsidiary

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

Supplemental Cash Flow Information:          
Cash paid for interest  $2,472   $4,124 
Cash paid for income taxes   3,948    1,805 
 Non cash investing and financing activities:          
Transfers from Fixed Assets to Other Assets  $727   $- 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 8 

 

Salisbury Bancorp, Inc. and Subsidiary

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - BASIS OF PRESENTATION

The interim (unaudited) consolidated financial statements of Salisbury Bancorp, Inc. ("Salisbury") include those of Salisbury and its wholly owned subsidiary, Salisbury Bank and Trust Company (the "Bank"). In the opinion of management, the interim unaudited consolidated financial statements include all adjustments (consisting of normal recurring adjustments) necessary to present fairly the consolidated financial position of Salisbury and the consolidated statements of income, comprehensive income, changes in shareholders' equity and cash flows for the interim periods presented.

The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). In preparing the financial statements, management is required to make extensive use of estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet, and revenues and expenses for the period. Actual results could differ significantly from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, other-than-temporary impairment of securities and impairment of goodwill and intangibles.

Certain financial information, which is normally included in financial statements prepared in accordance with generally accepted accounting principles, but which is not required for interim reporting purposes, has been condensed or omitted. Operating results for the interim period ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. The accompanying condensed financial statements should be read in conjunction with the financial statements and notes thereto included in Salisbury's 2020 Annual Report on Form 10-K for the year ended December 31, 2020.

The allowance for loan losses is a significant accounting policy and is presented in the Notes to Consolidated Financial Statements and in Management's Discussion and Analysis, which provides information on how significant assets are valued in the financial statements and how those values are determined. Based on the valuation techniques used and the sensitivity of financial statement amounts to the methods, assumptions and estimates underlying those amounts, management has identified the determination of the allowance for loan losses to be the accounting area that requires the most subjective judgments, and as such could be most subject to revision as new information becomes available.

Recent Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which adds a new Topic 326 to the Codification and removes the thresholds that companies apply to measure credit losses on financial instruments measured at amortized cost, such as loans, receivables, and held-to-maturity debt securities. Under current U.S. GAAP, companies generally recognize credit losses when it is probable that the loss has been incurred. The revised guidance will remove all recognition thresholds and will require companies to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the company expects to collect over the instrument's contractual life. ASU 2016-13 also amends the credit loss measurement guidance for available-for-sale debt securities and beneficial interests in securitized financial assets. In April 2019, the FASB issued ASU 2019-04 which clarified the treatment of accrued interest when measuring credit losses. Entities may: (1) measure the allowance for credit losses on accrued interest receivable balances separately from other components of the amortized cost basis of associated financial assets; (2) make various accounting policy elections regarding the treatment of accrued interest receivable; or (3) elect a practical expedient to disclose separately the total amount of accrued interest included in the amortized cost basis as a single balance to meet certain disclosure requirements. ASU 2019-04 also clarified that expected recoveries of amounts previously written off and expected to be written off should be included in the valuation account and should not exceed the aggregate of amounts previously written off and expected to be written off by the entity. In addition, for collateral dependent financial assets, the amendments clarify that an allowance for credit losses that is added to the amortized cost basis of the financial asset(s) should not exceed amounts previously written off. In November 2019, the FASB issued ASU 2019-10, which delayed the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for smaller reporting companies, although early adoption is permitted. Salisbury meets the definition of a smaller reporting company. In November 2019, the FASB issued ASU 2019-11, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses" which clarified or addressed specific issues about certain aspects of the amendments in ASU 2016-13. The amendments in ASU 2019-11 clarified the following: (1) The allowance for credit losses (ACL) for purchased financial assets with credit deterioration should include expected recoveries of amounts previously written off and expected to be written off by the entity and should not exceed the aggregate of amounts of the amortized cost basis previously written off and expected to be written off by an entity. In addition, the amendments clarify that when a method other than a discounted cash flow method is used to estimate expected credit losses, expected recoveries should not include any amounts that result in an acceleration of the noncredit discount. An entity may include increases in expected cashflows after acquisition; (2) Transition relief will be provided by permitting entities an accounting policy election to adjust the effective interest rate on existing troubled debt restructurings using prepayment assumptions on the date of adoption of Topic 326 rather than the prepayment assumptions in effect immediately before the restructuring; (3) Disclosure relief will be extended for accrued interest receivable balances to additional relevant disclosures involving amortized cost basis; (4) An entity should assess whether it reasonably expects the borrower will be able to continually replenish collateral securing the financial asset to apply the practical expedient. The amendments clarify that an entity applying the practical expedient should estimate expected credit losses for any difference between the amount of the amortized cost basis that is greater than the fair value of the collateral securing the financial asset (that is, the unsecured portion of the amortized cost basis). An entity may determine that the expectation of nonpayment for the amount of the amortized cost basis equal to the fair value of the collateral securing the financial asset is zero.

 9 

 

Upon adoption, Salisbury will apply the standards' provisions as a cumulative effect adjustment to retained earnings as of the first reporting period in which the guidance is effective. Salisbury anticipates that the adoption of ASU 2016-13 and related updates will impact the consolidated financial statements as it relates to the balance in the allowance for loan losses. Salisbury has engaged a third-party software vendor to model the allowance for loan losses in conformance with this ASU. Salisbury will continue to refine this model and assess the impact to its consolidated financial statements.

The Bank is working towards the completion of its ACL methodology. To estimate the ACL for loans and off-balance sheet credit exposures, such as unfunded loan commitments, the Bank will utilize a discounted cash flow model that contains additional assumptions to calculate credit losses over the estimated life of financial assets and off-balance sheet credit exposures and will include the impact of forecasted economic conditions. The estimate is expected to include a one-year reasonable and supportable forecast period and thereafter a one-year reversion period to the historical mean of its macroeconomic assumption. The estimate will also include qualitative factors that may not be reflected in quantitatively derived results to ensure that the ACL reflects a reasonable estimate of current expected credit losses.

Based on the credit quality of Salisbury's existing available for sale debt securities portfolio, which primarily consists of obligations of U.S. government agency and U.S. government-sponsored enterprise securities, including mortgage-backed securities, Salisbury does not expect the adoption of ASU 2016-13, as it relates to debt securities, to be significant. For available for sale debt securities with unrealized losses, credit losses will be recognized as an allowance rather than a reduction in the amortized cost of the securities. As a result, improvements to estimated credit losses will be recognized immediately in earnings rather than as interest income over time.

The Bank is currently refining various ACL assumptions and running parallel calculations on a monthly basis. Salisbury expects to complete independent model validation and to finalize its documentation of ACL processes and controls by the first quarter of 2023.

In December 2019, the FASB issued ASU 2019-12, "Simplifying the Accounting for Income Taxes." The amendments in this Update simplify the accounting for income taxes by removing the following exceptions:1. Exception to the incremental approach for intra-period tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income) 2. Exception to the requirement to recognize a deferred tax liability for equity method investments when a foreign subsidiary becomes an equity method investment 3. Exception to the ability not to recognize a deferred tax liability for a foreign subsidiary when a foreign equity method investment becomes a subsidiary 4. Exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year. The amendments in this Update also simplify the accounting for income taxes by doing the following: 1. Requiring that an entity recognize a franchise tax (or similar tax) that is partially based on income as an income-based tax and account for any incremental amount incurred as a non-income-based tax. 2. Requiring that an entity evaluate when a step-up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction. 3. Specifying that an entity is not required to allocate the consolidated amount of current and deferred tax expense to a legal entity that is not subject to tax in its separate financial statements. However, an entity may elect to do so (on an entity-by-entity basis) for a legal entity that is both not subject to tax and disregarded by the taxing authority. 4. Requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date. 5. Making minor Codification improvements for income taxes related to employee stock ownership plans and investments in qualified affordable housing projects accounted for using the equity method. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. On January 1, 2021, Salisbury adopted the new standard, which did not have a material impact on Salisbury's Consolidated Financial Statements.

In October 2020, the FASB issued ASU 2020-08, "Codification Improvements to Subtopic 310-20, Receivables - Nonrefundable Fees and Other Costs. Under current generally accepted accounting principles, entities amortize the premium on purchased callable debt securities to the earliest call date. If a callable debt security contains additional future call dates, entities should consider whether the amortized cost basis exceeded the amount repayable by the issuer at the next call date. If so, the excess or premium should be amortized to the next call date. This ASU clarifies that the next call date is the first date when a call option at a specified price becomes exercisable. Once that date has passed, the next call date is when the next call option at a specified price becomes exercisable, if applicable. If there is no remaining premium or if there are no further call dates, the entity shall reset the effective yield using the payment terms of the debt security. ASU 2020-08 is effective for interim and annual reporting periods beginning after December 15, 2020. On January 1, 2021, Salisbury adopted the new standard, which did not have a material impact on Salisbury's Consolidated Financial Statements.

In January 2021, the FASB issued ASU 2021-01, "Reference Rate Reform (Topic 848)." In response to the risk of cessation of the London Interbank Offered Rate (LIBOR) as a reference rate, this ASU clarifies the scope of Topic 848 so that derivatives affected by this transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. An entity may elect to apply the amendments in this ASU on a full retrospective basis as of any date from the beginning interim period that includes or is subsequent to March 12, 2020 or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final Update, up to the date that the financial statements are available to be issued. Salisbury is currently evaluating the impact of the transition from LIBOR to a new reference rate.

 10 

 

NOTE 2 - SECURITIES

The composition of securities is as follows:

(in thousands)   Amortized cost basis    Gross un-realized gains    Gross un-realized losses    Fair value 
September 30, 2021                    
Available-for-sale                    
U.S. Treasury  $10,397   $-   $95   $10,302 
U.S. Government Agency notes   32,093    280    99    32,274 
Municipal bonds   38,525    1,331    251    39,605 
Mortgage-backed securities:                    
U.S. Government agencies and U.S. Government- sponsored enterprises   67,059    818    698    67,179 
Collateralized mortgage obligations:                    
U.S. Government agencies   14,844    208    41    15,011 
Corporate bonds   11,000    197    -    11,197 
Total securities available-for-sale  $173,918   $2,834   $1,184   $175,568 
CRA mutual fund                                $907 
Non-marketable securities                    
Federal Home Loan Bank of Boston stock  $1,504   $-   $-   $1,504 
(in thousands)   Amortized cost basis    Gross un-realized gains    Gross un-realized losses    Fair value 
December 31, 2020                    
Available-for-sale                    
U.S. Government Agency notes  $7,735   $153   $37   $7,851 
Municipal bonds   25,831    1,787    1    27,617 
Mortgage-backed securities:                    
U.S. Government agencies and U.S. Government - sponsored enterprises   35,240    1,376    43    36,573 
Collateralized mortgage obligations:                    
U.S. Government agencies   17,054    400    -    17,454 
Corporate bonds   8,750    166    -    8,916 
Total securities available-for-sale  $94,610   $3,882   $81   $98,411 
CRA mutual fund                 $917 
Non-marketable securities                    
Federal Home Loan Bank of Boston stock  $1,713   $-   $-   $1,713 

 

In third quarter 2021, $7.0 million of available-for-sale securities were called, resulting in a pre-tax gain of $7 thousand and a related tax expense of $1.4 thousand. Salisbury did not sell any available-for-sale securities during the three month period ended September 30, 2021. Salisbury sold $3.3 million of available-for-sale securities during the nine month period ended September 30, 2021 realizing a pre-tax loss of $2 thousand and a related tax benefit of $0.4 thousand. Salisbury sold $1.9 million of available-for-sale securities during the three month period ended September 30, 2020 realizing a pre-tax gain of $34 thousand and related tax expense of $7 thousand. Salisbury sold $12.5 million of available-for-sale securities during the nine month period ended September 30, 2020 realizing a pre-tax gain of $216 thousand and a related tax expense of $45 thousand.

 11 

 

The following table summarizes the aggregate fair value and gross unrealized loss of securities that have been in a continuous unrealized loss position as of the date presented:

                   
   Less than 12 Months  12 Months or Longer  Total
September 30, 2021 (in thousands)  Fair value  Unrealized losses  Fair value  Unrealized losses  Fair value  Unrealized losses
Available-for-sale                  
U.S. Treasury  $10,302   $95   $-   $-   $10,302   $95 
U.S. Government Agency notes   20,550    80    1,125    19    21,675    99 
Municipal bonds   13,980    251    -    -    13,980    251 
Mortgage- backed securities:                              
U.S. Government agencies and U.S. Government - sponsored enterprises   42,471    647    1,398    26    43,869    698 
Collateralized mortgage obligations   4,625    66    -    -    4,625    41 
Corporate bonds   -    -    -    -    -    - 
Total temporarily impaired securities  $91,928   $1,139   $2,523   $45   $94,451   $1,184 
                               
                   
   Less than 12 Months  12 Months or Longer  Total
December 31, 2020 (in thousands)  Fair value  Unrealized losses  Fair value  Unrealized losses  Fair value  Unrealized losses
Available-for-sale                  
U.S. Government Agency notes  $2,553   $36   $20   $1   $2,573   $37 
Municipal bonds   558    1    -    -    558    1 
Mortgage- backed securities:                              
U.S. Government agencies and U.S. Government - sponsored enterprises   3,761    42    45    1    3,806    43 
Total temporarily impaired securities  $6,872   $79   $65   $2   $6,937   $81 

 

The table below presents the amortized cost, fair value and tax equivalent yield of securities, by maturity. Debt securities issued by U.S. Government agencies (SBA securities), MBS, and CMOS are disclosed separately in the table below as these securities may prepay prior to the scheduled contractual maturity dates.

September 30, 2021 (in thousands) Maturity Amortized cost Fair value Yield(1)
U.S. Treasury After 5 year but within 10 years $10,397 $10,302 1.15%
U.S. Government Agency notes After 5 year but within 10 years 15,902 15,848 1.23
Total 26,299 26,150 1.20
Municipal bonds After 5 year but within 10 years 3,594 3,820 2.80
After 10 years 34,931 35,785 2.61
Total 38,525 39,605 2.63
Mortgage-backed securities, Collateralized mortgage obligations, Securities not due at a single maturity date 98,094 98,616 1.64
Corporate bonds After 5 years but within 10 years 11,000 11,197 4.61
Securities available-for-sale $173,918 $175,568 2.04%

(1) Yield is based on amortized cost.

Salisbury evaluates debt securities for OTTI where the fair value of a security is less than its amortized cost basis at the balance sheet date. As part of this process, Salisbury considers whether it has the intent to sell each debt security and whether it is more likely than not that it will be required to sell the security before its anticipated recovery. If either of these conditions is met, Salisbury recognizes an OTTI charge to earnings equal to the entire difference between the security's amortized cost basis and its fair value at the balance sheet date. For securities that meet neither of these conditions, an analysis is performed to determine if any of these securities are at risk for OTTI.

The following summarizes, by security type, the basis for evaluating if the applicable securities were OTTI at September 30, 2021.

U.S. Treasury notes: The contractual cash flows are guaranteed by the U.S. government. Four securities had unrealized losses at September 30, 2021, which approximated 0.91% of their amortized cost. Changes in fair values are a function of changes in investment spreads and interest rate movements and not changes in credit quality since time of purchase. Management expects to recover the entire amortized cost basis of these securities. Furthermore, Salisbury evaluates these securities for strategic fit and may reduce its position in these securities, although it is not more likely than not that Salisbury will be required to sell these securities before recovery of their cost basis, which may be maturity, and does not intend to sell these securities. Management evaluated the impairment status of these debt securities, and concluded that the gross unrealized losses were temporary in nature. Therefore, management does not consider these investments to be other-than temporarily impaired at September 30, 2021.

 12 

 

U.S. Government Agency notes: The contractual cash flows are guaranteed by the U.S. government. Nineteen securities had unrealized losses at September 30, 2021, which approximated 0.45% of their amortized cost. Changes in fair values are a function of changes in investment spreads and interest rate movements and not changes in credit quality since time of purchase. Management expects to recover the entire amortized cost basis of these securities. Furthermore, Salisbury evaluates these securities for strategic fit and may reduce its position in these securities, although it is not more likely than not that Salisbury will be required to sell these securities before recovery of their cost basis, which may be maturity, and does not intend to sell these securities. Management evaluated the impairment status of these debt securities, and concluded that the gross unrealized losses were temporary in nature. Therefore, management does not consider these investments to be other-than temporarily impaired at September 30, 2021.

Municipal bonds: Salisbury performed a detailed analysis of the municipal bond portfolio. Sixteen securities had unrealized losses at September 30, 2021, which approximated 1.77% of their amortized cost. Management believes the unrealized loss position is attributable to interest rate and spread movements and not changes in credit quality. Management expects to recover the entire amortized cost basis of these securities. Furthermore, Salisbury evaluates these securities for strategic fit and may reduce its position in these securities, although it is not more likely than not that Salisbury will be required to sell these securities before recovery of their cost basis, which may be maturity, and does not intend to sell these securities. Management evaluated the impairment status of these debt securities, and concluded that the gross unrealized losses were temporary in nature. Therefore, management does not consider these investments to be other-than temporarily impaired at September 30, 2021.

U.S. Government agency and U.S. Government-sponsored enterprise securities and collateralized mortgage obligations: The contractual cash flows are guaranteed by U.S. government agencies and U.S. government-sponsored enterprises. Forty nine securities had unrealized losses at September 30, 2021, which approximated 1.51% of their amortized cost. Changes in fair values are a function of changes in investment spreads and interest rate movements and not changes in credit quality. Management expects to recover the entire amortized cost basis of these securities. Furthermore, Salisbury evaluates these securities for strategic fit and may reduce its position in these securities, although it is not more likely than not that Salisbury will be required to sell these securities before recovery of their cost basis, which may be maturity, and does not intend to sell these securities. Therefore, management does not consider these investments to be other-than-temporarily impaired at September 30, 2021.

The Federal Home Loan Bank of Boston (FHLBB) is a cooperative that provides services, including funding in the form of advances, to its member banking institutions. As a requirement of membership, the Bank must own a minimum amount of FHLBB stock, calculated periodically based primarily on its level of borrowings from the FHLBB. No market exists for shares of the FHLBB and therefore, they are carried at par value. FHLBB stock may be redeemed at par value five years following termination of FHLBB membership, subject to limitations which may be imposed by the FHLBB or its regulator, the Federal Housing Finance Board, to maintain capital adequacy of the FHLBB. While the Bank currently has no intentions to terminate its FHLBB membership, the ability to redeem its investment in FHLBB stock would be subject to the conditions imposed by the FHLBB. Based on the capital adequacy and the liquidity position of the FHLBB, management believes there is no impairment related to the carrying amount of the Bank's FHLBB stock as of September 30, 2021. Deterioration of the FHLBB's capital levels may require the Bank to deem its restricted investment in FHLBB stock to be OTTI. If evidence of impairment exists in the future, the FHLBB stock would reflect fair value using either observable or unobservable inputs. The Bank will continue to monitor its investment in FHLBB stock.

 13 

 

NOTE 3 - LOANS

The composition of loans receivable and loans held-for-sale is as follows:

(In thousands)    September 30, 2021     December 31, 2020  
Residential 1-4 family  $368,801   $352,001 
Residential 5+ multifamily   46,237    37,058 
Construction of residential 1-4 family   15,429    8,814 
Home equity lines of credit   24,001    27,804 
Residential real estate   454,468    425,677 
Commercial   314,820    310,841 
Construction of commercial   47,145    31,722 
Commercial real estate   361,965    342,563 
Farm land   3,409    3,198 
Vacant land   13,698    14,079 
Real estate secured   833,540    785,517 
Commercial and industrial ex PPP Loans   167,528    140,516 
PPP Loans   40,652    86,632 
Total Commercial and industrial   208,180    227,148 
Municipal   18,061    21,512 
Consumer   11,152    7,687 
Loans receivable, gross   1,070,933